The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Abstract
The 4-kilodalton (39 to 43 amino acids) amyloid β protein (βAP), which is deposited as amyloid in the brains of patients with Alzheimer's disease, is derived from a large protein, the amyloid β protein precursor (βAPP). Human mononuclear leukemic (K562) cells expressing a βAP-bearing, carboxyl-terminal βAPP derivative released significant amounts of a soluble 4-kilodalton βAPP derivative essentially identical to the βAP deposited in Alzheimer's disease. Human neuroblastoma (M17) cells transfected with constructs expressing full-length βAPP and M17 cells expressing only endogenous βAPP also released soluble 4-kilodalton βAP, and a similar, if not identical, fragment was readily detected in cerebrospinal fluid from individuals with Alzheimer's disease and normal individuals. Thus cells normally produce and release soluble 4-kilodalton βAP that is essentially identical to the 4-kilodalton βAP deposited as insoluble amyloid fibrils in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [5]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,359
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 919
Flagged first, then by citations
Research works printed but not linked: 5
- Cole, G. M., Molecular Biology and Genetics of Alzheimer's Disease: 113 (1990).
- FRUCHT, S. J., JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 51: 369 (1992).
- GLENNER, G, BRANBURY REPORT 15: 137 (1983).
- KIM, K.S., NEUROSCIENCE RESEARCH COMMUNICATIONS 2: 121 (1988).
- TERRY, R.D., BRAIN 311: 528 (1963).
Cited by
Sorted by citations
Items 801–900 of 1,002
Silva, O. A. B. D. C. E., Rebelo, S., Vieira, S. I., Gandy, S., Silva, E. F. D. C. E., & Greengard, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05770.x · Cited by 32
Kuperstein, F., Reiss, N. A., Koudinova, N. V., & Yavin, E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00037.x · Cited by 32
Genetic heterogeneity of gene defects responsible for familial Alzheimer disease
Tanzi, R. E., Gaston, S. M., Bush, A. I., Romano, D., Pettingell, W. H., Peppercorn, J. M., Paradis, M. D., Gurubhagavatula, S., Jenkins, B., & Wasco, W. (1993) · Genetica · doi:10.1007/bf01436002 · Cited by 32
Efthimiopoulos, S., Felsenstein, K. M., Sambamurti, K., Robakis, N. K. R. K., & Refolo, L. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380111 · Cited by 32
Citron, M., Haass, C., & Selkoe, D. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90041-9 · Cited by 31
Ru(II)-Dppz Derivatives and Their Interactions with DNA: Thirty Years and Counting
Pietro, M. L. D., Ganga, G. L., Nastasi, F., & Puntoriero, F. (2021) · Applied Sciences · doi:10.3390/app11073038 · Cited by 31
Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease
Qin, P., Ran, Y., Liu, Y., Wei, C., Luan, X., Niu, H., Peng, J., Sun, J., & Wu, J. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106090 · Cited by 31
Mandel, S. A., Morelli, M., Halperin, I. J. Y., & Korczyn, A. D. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0036-z · Cited by 36
Leclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 31
Decreasing amyloid toxicity through an increased rate of aggregation
Sonzini, S., Stanyon, H. F., & Scherman, O. A. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp06765d · Cited by 31
Nitsch, R. M., Slack, B. E., Farber, S. A., Schulz, J. G., Deng, M., Kim, C., Borghesani, P. R., Korver, W., Wurtman, R. J., & Growdon, J. H. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_2 · Cited by 31
Making models for Alzheimer's disease
Lamb, B. T. (1995) · Nature Genetics · doi:10.1038/ng0195-4 · Cited by 32
Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness
Shoji, M., & Kanai, M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3306 · Cited by 31
Self-citationGenes involved in Alzheimer's disease, a survey of possible candidates
Serretti, A., Artioli, P., Quartesan, R., & Ronchi, D. D. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7410 · Cited by 32
Nixon, R. A., & Cataldo, A. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90079-5 · Cited by 31
Proteoglycans and the acute-phase response in Alzheimer's disease brain
Leveugle, B., & Fillit, H. M. (1994) · Molecular Neurobiology · doi:10.1007/bf02816102 · Cited by 31
Convertases other than furin cleave β‐secretase to its mature form
Pinnix, I., Roseberry, B. J., Onstead, L., Mallender, W. D., Sucic, J. F., & Sambamurti, K. (2001) · The FASEB Journal · doi:10.1096/fj.00-0891fje · Cited by 31
The molecular genetics of Alzheimer's disease
MULLAN, M. J., & Crawford, F. (1994) · Molecular Neurobiology · doi:10.1007/bf02816100 · Cited by 32
Sun, X., Cole, G. M., Chu, T., Xia, W., Galasko, D., Yamaguchi, H., Tanemura, K., Frautschy, S. A., & Takashima, A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00265-2 · Cited by 30
The Search for an Amyloid Solution
Robinson, S. R., & Bishop, G. M. (2002) · Science · doi:10.1126/science.298.5595.962 · Cited by 31
Yamaguchi, H., Sugihara, S., Ishiguro, K., Takashima, A., & Hirai, S. (1995) · Amyloid · doi:10.3109/13506129509031882 · Cited by 31
The inorganic perspectives of neurotrophins and Alzheimer's disease
Travaglia, A., Pietropaolo, A., Mendola, D. L., Nicoletti, V. G., & Rizzarelli, E. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.10.017 · Cited by 31
Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis
Gandy, S., & Greengard, P. (1994) · Biochimie · doi:10.1016/0300-9084(94)90162-7 · Cited by 30
Wang, C., Cheng, F., Xu, L., & Jia, L. (2016) · RSC Advances · doi:10.1039/c6ra14590f · Cited by 32
Li, Q., Wu, D., Zhang, L., & Zhang, Y. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.06.008 · Cited by 30
Effect of ginkgolides on β‐amyloid‐suppressed acetylocholine release from rat hippocampal slices
Lee, T. F., Chen, C., & WANG, L. C. H. (2004) · Phytotherapy Research · doi:10.1002/ptr.1493 · Cited by 30
Alzheimer's Disease, ß-Amyloidosis, and Aging
Coria, F., Rubio, I., & Bayón, C. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.4.275 · Cited by 34
Helbling-Leclerc, A., Tomé, F. M. S., & Fardeau, M. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90021-b · Cited by 30
Cellular and molecular basis of beta-amyloid precursor protein metabolism
Xu, H. (1998) · Frontiers in bioscience · doi:10.2741/a283 · Cited by 30
Ritchie, C. W., Smailagic, N., Ladds, E. C., Noel-Storr, A. H., Ukoumunne, O. C., & Martin, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010803 · Cited by 31
Yoshihara, T., Takiguchi, S., Kyuno, A., Tanaka, K., Kuba, S., Hashiguchi, S., Ito, Y., Hashimoto, T., Iwatsubo, T., Tsuyama, S., et al. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm239 · Cited by 29
Molecular Dynamics Simulations of Anti-Aggregation Effect of Ibuprofen
Chang, W. E., Takeda, T., Raman, E. P., & Klimov, D. K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.02.031 · Cited by 28
Spoerri, L., Vella, L. J., Pham, C. L. L., Barnham, K. J., & Cappai, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355743 · Cited by 29
Chen, Z., Maqbool, J., Sajid, F., Hussain, G., & Sun, T. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104675 · Cited by 28
Scherberich, J. E., Kellermeyer, M., Ried, C., & Hartinger, A. (2005) · PubMed · Cited by 29
Infection‐induced endothelial amyloids impair memory
Balczon, R., Pittet, J., Wagener, B. M., Moser, S. A., Voth, S. B., Vorhees, C. V., Williams, M. T., Bridges, J. P., Alvarez, D. F., Koloteva, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900322r · Cited by 28
Chu, T., Tran, T., Yang, F., Beech, W. K., Cole, G. M., & Frautschy, S. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01161-2 · Cited by 29
Klunk, W. E., Xu, C., McClure, R. J., Panchalingam, K., Stanley, J. A., & Pettegrew, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010266.x · Cited by 29
Dillen, K., & Annaert, W. G. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)54005-7 · Cited by 29
Hajimohammadreza, I., Anderson, V., Cavanagh, J. B., Seville, M. P., Nolan, C. C., Anderton, B. H., & Leigh, P. N. (1994) · Brain Research · doi:10.1016/0006-8993(94)91853-8 · Cited by 28
Felsenstein, K. M., & Lewis‐Higgins, L. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90514-l · Cited by 29
Ghosh, C., Mukherjee, S., Seal, M., & Dey, S. G. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b02683 · Cited by 29
Koudinova, N. V., Koudinov, A. R., & Yavin, E. (2000) · Neurochemical Research · doi:10.1023/a:1007511120099 · Cited by 28
Transforming growth factor β2 autocrinally mediates neuronal cell death induced by amyloid‐β
Hashimoto, Y., Nawa, M., Chiba, T., Aiso, S., Nishimoto, I., & Matsuoka, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20804 · Cited by 29
Inestrosa, N. C., Alarcón, R., Arriagada, J., Donoso, A., & Alvarez, J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90216-8 · Cited by 27
Smith, C. J., & Anderton, B. H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00977.x · Cited by 27
Roles for calcium signaling in structural plasticity and pathology in the hippocampal system
Mattson, M. P., & Barger, S. W. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030711 · Cited by 36
Giudice, E. D., Facchinetti, F., Nofrate, V., Boccaccio, P., Minelli, T. A., Dam, M., Leon, A., & Moschini, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.057 · Cited by 27
Analysis of the Proteomic Profiling of Brain Tissue in Alzheimer′s Disease
Tsuji, T., & Shimohama, S. (2001) · Disease Markers · doi:10.1155/2001/386284 · Cited by 27
What Is Primary and What Secondary for Amyloid Deposition in Alzheimer's Disease
Meier‐Ruge, W., Iwangoff, P., & Bertoni–Freddari, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56831.x · Cited by 27
Haas, U., & Sparks, D. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815189 · Cited by 27
Brunkan, A. L., Martinez, M., Wang, J., Walker, E. S., Beher, D., Shearman, M. S., & Goate, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03278.x · Cited by 27
Akaaboune, M., Ma, J., Festoff, B. W., Greenberg, B., & Hantaı̈, D. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250505 · Cited by 27
White matter amyloid in Alzheimer's disease brain
Uchihara, T., Kondo, H., Akiyama, H., & Ikeda, K. (1995) · Acta Neuropathologica · doi:10.1007/bf00294459 · Cited by 27
Role of Apolipoprotein E in Alzheimer’s Disease
Zannis, V. I., Zanni, E. E., Makrides, S. C., Kardassis, D., & Aleshkov, S. B. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_13 · Cited by 26
Pawlik, M., Sastre, M., Calero, M., Mathews, P. M., Schmidt, S. D., Nixon, R. A., & Levy, E. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:13 · Cited by 26
The mechanism for heme to prevent Aβ1–40 aggregation and its cytotoxicity
Bao, Q., Luo, Y., Li, W., Sun, X., Zhu, C., Li, P., Huang, Z., & Tan, X. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0783-x · Cited by 26
Enhancement of proteolytic processing of the β-amyloid precursor protein by hyperforin
Froestl, B., Steiner, B., & Müller, W. E. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.010 · Cited by 26
Neuronal dysfunction in Down syndrome: Contribution of neuronal models in cell culture
Saud, K., Arriagada, C., Cárdenas, A. M., Shimahara, T., Allen, D. D., Caviedes, R., & Caviedes, P. A. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.013 · Cited by 26
Chapter 21. Alzheimer's Disease: Current Therapeutic Approaches
John, V., Lieberburg, I. M., & Thorsett, E. D. (1993) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60891-x · Cited by 26
Seo, H., Ferree, A. W., & Ole Isacson, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01884.x · Cited by 26
Moechars, D., Lorent, K., Dewachter, I., Baekelandt, V., Strooper, B. D., & LEUVEN, F. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00210-6 · Cited by 27
Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease
Kudo, Y. (2006) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645700600836000 · Cited by 25
Restraint stress induces β-amyloid precursor protein mRNA expression in the rat basolateral amygdala
Rosa, M. L. N. M., Guimarães, F. S., de Oliveira, R. M. W., Padovan, C. M., Pearson, R. C. A., & Bel, E. A. D. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.011 · Cited by 25
The Golgi apparatus and the pathogenesis of Alzheimer's disease.
Canto, M. C. D. (1996) · Europe PMC (PubMed Central) · Cited by 24
Ghosh, C., & Dey, S. G. (2013) · Inorganic Chemistry · doi:10.1021/ic301865n · Cited by 25
New approaches to diagnose and treat alzheimer's disease
Galasko, D. R. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70075-6 · Cited by 25
Endosomal Sorting of Amyloid Precursor Protein‐P‐Selectin Chimeras Influences Secretase Processing
Daugherty, B. L., & Green, S. A. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.21206.x · Cited by 25
Schwarzman, A. L., Tsiper, M. V., Gregori, L. L., Goldgaber, D., Frackowiak, J., Mazur‐Kolecka, B., Taraskina, A. E., Пчелина, С. Н., & Vitek, M. P. (2005) · Amyloid · doi:10.1080/13506120500350762 · Cited by 26
Bullido, M. J., Muñoz‐Fernández, M. Á., Recuero, M., Fresno, M., & Valdivieso, F. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00015-8 · Cited by 25
β-Amyloid therapies in Alzheimer’s disease
Jhee, S. S., Shiovitz, T. M., Crawford, A. W., & Cutler, N. R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.593 · Cited by 25
Cheung, T. T., Ghiso, J. A., Shojif, M., Cai, X.-D., Golde, T. E., Gandy, S., Frangione, B., & Younkin, S. G. (1994) · Amyloid · doi:10.3109/13506129409148622 · Cited by 25
Self-citationGreenberg, B. (1995) · Amyloid · doi:10.3109/13506129509036927 · Cited by 25
Valverde, A., Dunys, J., Lorivel, T., Debayle, D., Gay, A.-S., Caillava, C., Chami, M., & Checler, F. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100963 · Cited by 24
Inflammation in Alzheimer’s disease
Heneka, M. T. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.005 · Cited by 25
Bora, R. P., & Prabhakar, R. S. (2009) · The Journal of Chemical Physics · doi:10.1063/1.3249609 · Cited by 24
Takeda, T., Kumar, R., Raman, E. P., & Klimov, D. K. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp107955v · Cited by 24
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
Self-citationNeurotoxic Traffic: Uncovering the Mechanics of Amyloid Production in Alzheimer's Disease
Huse, J. T., & Doms, R. W. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.020201.x · Cited by 24
Racchi, M., Ianna, P., Binetti, G. G., Trabucchi, M., & Govoni, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3301271 · Cited by 24
Golabek, A. A., Kida, E., Walus, M., Perez, C., Wısnıewskı, T., & Soto, C. A. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76354-5 · Cited by 24
Aluminum-sensitive degradation of amyloid β-protein1–40 by murine and human intracellular enzymes
Banks, W. A. (1996) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(96)00084-0 · Cited by 23
Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease
Selkoe, D. J. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00016-5 · Cited by 24
Increased amyloid production from aberrant beta-amyloid precursor proteins.
Zhong, Z., Quon, D. H., Higgins, L. S., Higaki, J. N., & Cordell, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32698-4 · Cited by 24
Molecular biology of brain aging and neurodegenerative disorders
Wısnıewskı, T., & Frangione, B. (1996) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1996-1132 · Cited by 24
Self-citationEckert, A., Förstl, H., Zerfaß, R., Hartmann, H., & Müller, W. E. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00329-3 · Cited by 24
Marks, N., Berg, M. J., Chi, L.-M., Choi, J. H. K., Durrie, R., Swistok, J., MAKOFSKE, R. C., Danho, W., & Sapirstein, V. S. (1994) · Peptides · doi:10.1016/0196-9781(94)90188-0 · Cited by 24
Lee, H., Petersen, R. B., Zhu, X., Honda, K., Aliev, G., Smith, M. A., & Perry, G. L. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00491.x · Cited by 24
Li, L.-B., & Wang, Z. (2016) · PubMed · doi:10.14670/hh-11-737 · Cited by 23
Waigi, E. W., Webb, R. C., Moss, M. A., Uline, M. J., McCarthy, C. G., & Wenceslau, C. F. (2023) · GeroScience · doi:10.1007/s11357-023-00748-y · Cited by 26
Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Alkadhi, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376307 · Cited by 23
Does Diet Have a Role in the Treatment of Alzheimer's Disease?
Thelen, M., & Brown‐Borg, H. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.617071 · Cited by 24
Glycosaminoglycan‐induced activation of the β‐secretase (BACE1) of Alzheimer’s disease
Klaver, D. W., Wilce, M. C. J., Gasperini, R., Freeman, C. G., Juliano, J. P., Parish, C. R., Foa, L. C., Aguilar, M., & Small, D. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06571.x · Cited by 23
Shepherd, C. E., Bowes, S., Parkinson, D., Cambray-Deakin, M. A., & Pearson, R. C. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00197-4 · Cited by 23
Reduction of Plasma Glutamyl Aminopeptidase Activity in Sporadic Alzheimer's Disease
Kuda, T., Shoji, M., Arai, H., Kawashima, S., & Saido, T. C. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5920 · Cited by 22
Self-citationBernstein, H., Rinne, R., Kirschke, H., Järvinen, M., Knöfelh, B., & Rinne, A. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90071-x · Cited by 23
Pharmacotherapy for Alzheimer’s Disease
Whitehouse, P. J., & Geldmacher, D. (1994) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30349-5 · Cited by 23
Majocha, R. E., Agrawal, S., Tang, J., Humke, E. W., & Marotta, C. A. (1994) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088829 · Cited by 22
Singh, V. K., Cheng, J., & Leu, S.-J. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)91313-7 · Cited by 23
Neuronal loss and β-amyloid removal in the amygdala of people with Down syndrome☆
Węgiel, J., Wı́sniewski, H. M., Moryś, J., Tarnawski, M. J., Kuchna, I., Dziewíatkowski, J., Pirttilä, T., Krivimäki, T., Lehtimäki, T. J., & Lach, B. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00060-3 · Cited by 23
Metadata
- Authors
- Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., & Younkin, S. G.
- Affiliations
- Gunma University (JP)
- Case Western Reserve University (US)
- NYU Langone Health (US)
- Washington University in St. Louis (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- Science
- Published
- 1992-10-02
- Volume
- 258
- Issue
- 5079
- Pages
- 126-129
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033382511
- Cited by
- 1,447
- References
- 32
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 16 · 2023: 13 · 2022: 13 · 2021: 18 · 2020: 23 · 2019: 16 · 2018: 18 · 2017: 15 · 2016: 37 · 2015: 26 · 2014: 28 · 2013: 38 · 2012: 37
- FWCI
- 80.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG06656, R01AG006656, AG05891)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR02594)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, Alzheimer's disease, amyloid precursor protein, proteolytic processing, soluble amyloid-beta, amyloid fibrils, cerebrospinal fluid, K562 cells, neuroblastoma cells, transfection, protein secretion
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Base Sequence, Cell Line, Leukemia, Myeloid, Molecular Sequence Data, Neuroblastoma, Transfection, Immunoblotting, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review